Australia Wound Biologics Market Size & Outlook, 2024-2030
Related Markets
Australia wound biologics market highlights
- The Australia wound biologics market generated a revenue of USD 32.2 million in 2023 and is expected to reach USD 55.0 million by 2030.
- The Australia market is expected to grow at a CAGR of 8.1% from 2024 to 2030.
- In terms of segment, biological skin substitutes was the largest revenue generating type in 2023.
- Biological Skin Substitutes is the most lucrative type segment registering the fastest growth during the forecast period.
Wound biologics market data book summary
| Market revenue in 2023 | USD 32.2 million |
| Market revenue in 2030 | USD 55.0 million |
| Growth rate | 8.1% (CAGR from 2024 to 2030) |
| Largest segment | Biological skin substitutes |
| Fastest growing segment | Biological Skin Substitutes |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Biological Skin Substitutes, Topical Agents, Collagen Dressing |
| Key market players worldwide | Molnlycke Health Care, Osiris Therapeutics, Integra LifeSciences, Wright Medical Group, Smith & Nephew PLC |
Other key industry trends
- In terms of revenue, Australia accounted for 1.4% of the global wound biologics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, India wound biologics market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 118.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Wound Biologics Market Scope
Wound Biologics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Wright Medical Group | View profile | 1001-5000 | Arlington, Tennessee, United States, North America | http://www.wright.com/ |
| Osiris Therapeutics | View profile | 501-1000 | Columbia, Maryland, United States, North America | http://osiris.com |
| Molnlycke Health Care | View profile | 5001-10000 | Gothenburg, Vastra Gotaland, Sweden, Europe | http://www.molnlycke.com/ |
| Integra LifeSciences | View profile | 5001-10000 | Princeton, New Jersey, United States, North America | http://www.integralife.com |
| Smith & Nephew PLC | View profile | 18452 | Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, United Kingdom, WD18 8YE | https://www.smith-nephew.com |
Australia wound biologics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to wound biologics market will help companies and investors design strategic landscapes.
Biological skin substitutes was the largest segment with a revenue share of 69.57% in 2023. Horizon Databook has segmented the Australia wound biologics market based on biological skin substitutes, topical agents, collagen dressing covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Australia wound biologics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia wound biologics market databook
-
Our clientele includes a mix of wound biologics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia wound biologics market , including forecasts for subscribers. This country databook contains high-level insights into Australia wound biologics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Australia wound biologics market size, by type, 2018-2030 (US$M)
Australia Wound Biologics Market Outlook Share, 2023 & 2030 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
